1. Home
  2. PRTC vs RC Comparison

PRTC vs RC Comparison

Compare PRTC & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$16.91

Market Cap

386.7M

Sector

Health Care

ML Signal

HOLD

Logo Ready Capital Corproation

RC

Ready Capital Corproation

HOLD

Current Price

$2.23

Market Cap

424.8M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTC
RC
Founded
2015
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
386.7M
424.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRTC
RC
Price
$16.91
$2.23
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$5.75
AVG Volume (30 Days)
4.8K
3.1M
Earning Date
08-28-2025
11-06-2025
Dividend Yield
N/A
20.92%
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$6,391,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$32.94
P/E Ratio
$7.77
N/A
Revenue Growth
1265.60
N/A
52 Week Low
$13.30
$2.32
52 Week High
$23.35
$7.64

Technical Indicators

Market Signals
Indicator
PRTC
RC
Relative Strength Index (RSI) 51.09 30.08
Support Level $16.44 $2.37
Resistance Level $17.17 $2.53
Average True Range (ATR) 0.35 0.13
MACD 0.12 -0.00
Stochastic Oscillator 55.29 15.67

Price Performance

Historical Comparison
PRTC
RC

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About RC Ready Capital Corproation

Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.

Share on Social Networks: